Sanofi (SNY) Net Income - Minority (2009)
Sanofi's (SNY) quarterly Net Income - Minority came in at -$381.0 million in Q4 2009, down 333.7% quarter-over-quarter from $163.0 million in Q3 2009.
Sanofi (SNY) Net Income - Minority (2009) Analysis & Trends
Sanofi has disclosed Net Income - Minority across 1 years of filings, most recently posting -$381.0 million for Q4 2009.
- Net Income - Minority for Q4 2009 came in at -$381.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2009 was -$381.0 million (changed N/A YoY), and the FY2009 annual result was -$381.0 million, changed N/A from the prior year.
- Net Income - Minority came in at -$381.0 million for Q4 2009 at Sanofi, down from $163.0 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of $163.0 million in Q3 2009 to a low of -$381.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | - |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | - |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | - |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | - |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | - |
| 10 | Sanofi | 62.37 Mn | -6.87 Bn | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -381.00 Mn |
| Sep 30, 2009 | 163.03 Mn |
| Jun 30, 2009 | -221.95 Mn |
| Mar 31, 2009 | 158.24 Mn |